G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, Alters In vitro Endothelial Cell Growth and Tubular Morphogenesis | Citedby Results | Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, Alters In vitro Endothelial Cell Growth and Tubular Morphogenesis

Clin Cancer Res (2009) 15 (8): 2797–2807.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo

Yuan Ma
Wenting Zhao
Yiding Li
Yufei Pan
Shuhe Wang
Yuejie Zhu
Lingxuan Kong
Zhu Guan
Jiancheng Wang
Lihe Zhang
Zhenjun Yang

Biomaterials (2019) 197: 182.

Inflammatory bowel disease: new therapies from antisense oligonucleotides

Irene Marafini
Giovanni Monteleone

Annals of Medicine (2018) 50 (5): 361.

The chemical evolution of oligonucleotide therapies of clinical utility

Anastasia Khvorova
Jonathan K Watts

Nature Biotechnology (2017) 35 (3): 238.

Electronic Structures of LNA Phosphorothioate Oligonucleotides

Henrik G. Bohr
Irene Shim
Cy Stein
Henrik Ørum
Henrik F. Hansen
Troels Koch

Molecular Therapy - Nucleic Acids (2017) 8: 428.

Antisense Approach to Inflammatory Bowel Disease: Prospects and Challenges

Irene Marafini
Davide Di Fusco
Emma Calabrese
Silvia Sedda
Francesco Pallone
Giovanni Monteleone

Drugs (2015) 75 (7): 723.

Quantum Mechanical Studies of DNA and LNA

Troels Koch
Irene Shim
Morten Lindow
Henrik Ørum
Henrik G. Bohr

Nucleic Acid Therapeutics (2014) 24 (2): 139.

Antisense oligonucleotides in cancer

Daniela Castanotto
Cy A. Stein

Current Opinion in Oncology (2014) 26 (6): 584.

BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma

Philippe Ratajczak
Christophe Leboeuf
Li Wang
Josette Brière
Irmine Loisel-Ferreira
Catherine Thiéblemont
Wei-Li Zhao
Anne Janin

Modern Pathology (2012) 25 (6): 805.

Stromal Cell-Derived Factor 1 Regulates the Actin Organization of Chondrocytes and Chondrocyte Hypertrophy

Koichi Murata
Toshiyuki Kitaori
Shinya Oishi
Naoki Watanabe
Hiroyuki Yoshitomi
Shimei Tanida
Masahiro Ishikawa
Takashi Kasahara
Hideyuki Shibuya
Nobutaka Fujii
Takashi Nagasawa
Takashi Nakamura
Hiromu Ito
Jialin Charles Zheng

PLoS ONE (2012) 7 (5): e37163.

Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents

Adrian G. Torres
Richard N. Threlfall
Michael J. Gait

Artificial DNA: PNA & XNA (2011) 2 (3): 71.

Immunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle

MASAAKI IWAHASHI
YASUTERU MURAGAKI
MAKOTO IKOMA
YASUSHI MABUCHI
AYA KOBAYASHI
YUUKO TANIZAKI
KAZUHIKO INO

Experimental and Therapeutic Medicine (2011) 2 (2): 287.

Off-Target Effects Related to the Phosphorothioate Modification of Nucleic Acids

Johannes Winkler
Martina Stessl
Jennifer Amartey
Christian R. Noe

ChemMedChem (2010) 5 (8): 1344.

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents

C. A. Stein
J. Bo Hansen
Johnathan Lai
SiJian Wu
Anatoliy Voskresenskiy
Anja H⊘g
Jesper Worm
Maj Hedtjärn
Naira Souleimanian
Paul Miller
Harris S. Soifer
Daniella Castanotto
Luba Benimetskaya
Henrik Ørum
Troels Koch

Nucleic Acids Research (2010) 38 (1): e3.